IRON: Disc Medicine, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,417.33
Enterprise Value ($M) 1,253.22
Book Value ($M) 443.59
Book Value / Share 12.83
Price / Book 3.20
NCAV ($M) 440.43
NCAV / Share 12.74
Price / NCAV 3.22

Profitability (mra)
Return on Invested Capital (ROIC) -0.23
Return on Assets (ROA) -0.31
Return on Equity (ROE) -0.32

Liquidity (mrq)
Quick Ratio 21.17
Current Ratio 21.17

Balance Sheet (mrq) ($M)
Current Assets 493.62
Assets 496.77
Liabilities 53.19
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -129.72
Net Income -109.36

Cash Flow Statement (mra) ($M)
Cash From Operations -93.93
Cash from Investing -292.33
Cash from Financing 218.31

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-12 13D/A Orbimed Advisors Llc 4.50 -12.84
03-03 13D/A Ai Dmi Llc 10.80 0.00
02-14 13G/A Bain Capital Life Sciences Opportunities III, LP 3.30 -45.23
02-12 13G Fmr Llc 6.30 -13.87
02-10 13G/A Wellington Management Group Llp 4.70 -24.17
11-14 13G/A Paradigm Biocapital Advisors LP 5.04 -37.23
11-08 13G BlackRock, Inc. 6.20 0.00
06-25 13G Frazier Life Sciences Public Fund, L.P. 5.90

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 108,919 307,504 35.42
2025-04-16 198,883 498,248 39.92
2025-04-15 103,193 369,529 27.93
2025-04-14 95,916 344,438 27.85

(click for more detail)

Similar Companies
IKNA – Ikena Oncology, Inc. IMRX – Immuneering Corporation
IOVA – Iovance Biotherapeutics, Inc. ITOS – iTeos Therapeutics, Inc.
IVVD – Invivyd, Inc.


Financial data and stock pages provided by
Fintel.io